Abstract
1-[4-(3-Acetyl-2,4,6-trimethylphenyl)-2,6-cyclohexanedionyl]-O-ethyl propionaldehyde oxime (for short ATMP) is a novel porphyrogenic agent causing hepatic protoporphyria in the mouse. Mice given a single dose of the drug showed 24 h later a 70% inhibition of liver ferrochelatase and marked accumulation of protoporphyrin. These changes were not seen in similarly treated rats, guinea pigs, hamsters or chick embryos. A green pigment was isolated from the liver of mice treated with ATMP and identified by its electronic absorption spectrum and chromatographic properties on HPLC asN-methyl protoporphyrin. The ATMP pigment markedly inhibited the enzyme ferrochelatase in vitro, thus supporting its identification asN-methyl protoporphyrin. Two inhibitors of liver cytochrome P450, compound SKF 525-A and piperonyl butoxide, when given before ATMP, afforded protection against ATMP-induced porphyria and production ofN-methyl protoporphyrin, suggesting a role of cytochrome P450 in the induction of the metabolic disorder. The most likely interpretation for these findings is therefore that ATMP is metabolized in the mouse to a reactive species, which in turn alkylates the haem moiety of liver cytochrome P450, thus producingN-methyl protoporphyrin. This inhibits ferrochelatase and, as a secondary response, protoporphyrin accumulates. This pathway of metabolism to the postulated reactive metabolite presumably does not occur to a significant extent in the other species examined and hence is the likely basis for the species difference in protoporphyria.
Similar content being viewed by others
References
Abbritti G, De Matteis F (1971) Decreased levels of cytochrome P450 and catalase in hepatic porphyria caused by substituted acetamides and barbiturates. Chem Biol Interact 4: 281–286
Augusto O, Beilan HS, Ortiz de Montellano PR (1982) The catalytic mechanism of cytochrome P450: spin-trapping evidence for oneelectron oxidation. J Biol Chem 257: 11288–11295
Cole SPC, Witney RA, Marks GS (1981) Ferrochelatase inhibitory and porphyrin-inducing properties of 3,5-diethoxycarbonyl-1,4-dihydro-2,4,6-trimethyl pyridine and its analogues in chick embryo liver cells. Mol Pharmacol 20: 395–403
Coffman BL, Ingall G, Tephly TR (1982) The formation of N-alkylprotoporphyrin IX and destruction of cytochrome P450 in the liver of rats after treatment with 3,5-diethoxycarbonyl-1,4-dihydrocollidine and its 4-ethyl analog. Arch Biochem Biophys 218: 220–224
De Matteis F, Cantoni L (1979) Alteration of the porphyrin nucleus of cytochrome P-450 caused in the liver by treatment with allyl-containing drugs. Is the modified porphyrinN-substituted? Biochem J 183: 99–103
De Matteis F, Gibbs AH (1980) Drug-induced conversion of liver haem into modified porphyrins: evidence for two classes of products. Biochem J 187: 285–288
De Matteis F, Abbritti G, Gibbs AH (1973) Decreased liver activity of porphyrin-metal chelatase in hepatic porphyria caused by DDC: studies in rat and mice. Biochem J 134: 717–727
De Matteis F, Gibbs AH, Tephly TR (1980 a) Inhibition of protohaem ferro-lyase in experimental porphyria. Isolation and partial characterization of a modified porphyrin inhibitor. Biochem J 188: 145–152
De Matteis F, Gibbs AH, Jackson AH, Weerasinghe S (1980 b) Conversion of liver haem into N-substituted porphyrins or green pigments. Nature of the substituent at the pyrrole nitrogen atom. FEBS Lett 119: 109–112
De Matteis F, Gibbs AH, Farmer PB, Lamb JH (1981) Liver production of N-alkylated porphyrins caused in mice by treatment with substituted dihydropyridines: evidence that the alkyl group on the pyrrole nitrogen atom originates from the drug. FEBS Lett 129: 328–331
De Matteis F, Holland C, Gibbs AH, De Sa N, Rizzardini M (1982) Inactivation of cytochrome P450 and production of N-alkylated porphyrins caused in isolated hepatocytes by substituted dihydropyridines. Structural requirements for loss of haem and alkylation of the pyrrole nitrogen atom. FEBS Lett 145: 87–92
De Matteis F, Gibbs AH, Holley AE (1987) Occurrence and biological properties ofN-methyl protoporphyrin. Ann NY Acad Sci 514: 30–40
Ferioli A, Harvey C, De Matteis F (1984) Drug-induced accumulation of uroporphyrin in chicken hepatocytes cultures. Structural requirements for the effect and role of exogenous iron. Biochem J 224: 769–777
Grandchamp B, Deybach JC, Grelier M, De Verneuil H, Nordman Y (1980) Studies of porphyrin synthesis in fibroblasts of patients with congenital erythropoietic porphyria and one patient with homozygous coproporphyria. Biochim Biophys Acta 629: 577–586
Holley A, King LJ, Gibbs AH, De Matteis F (1990) Strain and sex differences in the response of mice to drugs that induce protoporphyria: role of porphyrin biosynthesis and removal. J Biochem Toxicol 5: 175–182
Holley A, Frater YA, Gibbs AH, De Matteis F, Lamb JH, Farmer PB, Naylor S (1991) Isolation of twoN-monosubstitutedprotoporphyrins bearing either the whole drug or a methyl group on the pyrrole nitrogen atom, from liver of mice given griseofulvin. Biochem J 274: 843–848
Jones MS, Jones OTG (1969) The structural organization of haem synthesis in rat liver mitochondria. Biochem J 113: 507–514
Kamath SA, Rubin E (1972) Interaction of calcium with microsomes: a modified method for the rapid isolation of rat liver microsomes. Biochem Biophys Res Commun 49: 52–59
Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193: 265–275
Marks GS, Allen DT, Johnston CT, Sutherland EP, Nakatsu K, Whitney RA (1985) Suicidal destruction of cytochrome P-450 and reduction of ferrochelatase activity by 3,5-diethoxycarbonyl-1,4-dihydro-2,4,6-trimethylpyridine and its analogues in chick embryo liver cells. Mol Pharmacol 27: 459–465
Marks GS, McCluskey SA, Mackie JE, Riddick DS, James CA (1988) Disruption of hepatic heme biosynthesis after interaction of xenobiotics with cytochrome P-450. FASEB J 2: 2774–2783
Omura T, Sato R (1964) The carbon monoxide-binding pigment of liver microsomes. J Biol Chem 239: 2370–2379
Ortiz de Montellano PR, Beilan HS, Kunze KL (1981a)N-Methyl-protoporphyrin IX: chemical synthesis and identification as the green pigment produced by 3,5-diethoxycarbonyl-1,4-dihydrocollidine treatment. Proc Natl Acad Sci USA 78: 1490–1494
Ortiz de Montellano PR, Beilan HS, Kunze KL (1981b)N-Alkyl-protoporphyrin IX: formation in 3,5-dicarbethoxy-1,4-dihydrocollidinetreated rats. Transfer of the alkyl group from the substrate to the porphyrin. J Biol Chem 256: 6708–6713
Smith AG, Francis JE (1979) Decarboxylation of porphyrinogens by rat liver uroporphyrinogen decarboxylase. Biochem J 183: 455–458
Tephly TR, Gibbs AH, De Matteis F (1979) Studies on the mechanism of experimental porphyria produced by 3,5-diethoxycarbonyl-1,4-dihydrocollidine: role of a porphyrin-like inhibitor of protohaem ferrolyase. Biochem J 180: 241–244
Tephly TR, Gibbs AH, Ingall G, De Matteis F (1980) Studies on the mechanism of experimental porphyria and ferrochelatase inhibition produced by 3,5-diethoxycarbonyl-1,4-dihydrocollidine. Int J Biochem 12: 993–998
Tephly TR, Coffman BL, Ingall G, Abou Zeit-Har MS, Goff HM, Tabba HD, Smith KM (1981) Identification ofN-methyl protoporphyrin IX in livers of untreated mice and mice treated with 3,5-diethoxycarbonyl-1,4-dihydrocollidine: source of the methyl group. Arch Biochem Biophys 212: 120–126
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Frater, Y., Brady, A., Lock, E.A. et al. Formation of N-methyl protoporphyrin in chemically-induced protoporphyria. Arch Toxicol 67, 179–185 (1993). https://doi.org/10.1007/BF01973305
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01973305